Amedisys Inc (AMED)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	127,106	180,739	192,621	166,301	156,394	168,623	165,343	175,189	180,772	182,693	200,534	231,028	251,915	265,909	272,450	244,247	219,268	198,668	182,199	177,018
Revenue (ttm)	US$ in thousands	2,348,324	2,321,060	2,289,626	2,251,407	2,236,382	2,227,658	2,229,409	2,234,331	2,223,199	2,220,452	2,215,949	2,222,225	2,214,112	2,205,500	2,196,085	2,116,978	2,071,519	2,021,492	1,972,053	1,979,978
Operating profit margin		5.41%	7.79%	8.41%	7.39%	6.99%	7.57%	7.42%	7.84%	8.13%	8.23%	9.05%	10.40%	11.38%	12.06%	12.41%	11.54%	10.58%	9.83%	9.24%	8.94%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $127,106K ÷ $2,348,324K
= 5.41%

Amedisys Inc's operating profit margin has displayed fluctuations over the quarters from March 31, 2020, to December 31, 2024. The margin started at 8.94% in March 2020, increased steadily to a peak of 12.41% by June 30, 2021, before experiencing a slight decrease to 11.38% by December 31, 2021. However, from there, the margin began to decline more significantly, reaching a low of 5.41% by December 31, 2024.

The general trend indicates a period of growth and stability in the operating profit margin followed by a marked decrease in the later quarters. This downward trend may raise concerns about the company's ability to maintain profitability and control operating expenses effectively.

It would be advisable for stakeholders and investors to closely monitor Amedisys Inc's operating profit margin in upcoming periods to assess whether the decline is temporary or indicates broader performance challenges that require attention and management intervention.